Role of fetal echocardiography in stepwise sequential screening for chromosomal disorders (combined test associated with modified genetic sonography)

References

• Breathnach FM, Fleming A, Malone FD. The second trimester genetic sonogram. Am J Med Genet C Semin Med Genet 2007;145C:62–72.
   PubMedGoogle Scholar
• Benacerraf BR. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice. Prenat Diagn 2010;30:644–652.
   PubMedGoogle Scholar
• Nyberg DA, Souter VL, El-Bastawissi A, Young S, Luthhardt F, Luthy DA. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med 2001;20:1053–1063.
   PubMed Web of Science ®Google Scholar
• Bromley B, Lieberman E, Shipp TD, Benacerraf BR. The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med 2002;21:1087–96; quiz 1097.
   PubMed Web of Science ®Google Scholar
• Hobbins JC, Lezotte DC, Persutte WH, DeVore GR, Benacerraf BR, Nyberg DA, Vintzileos AM, et al. An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies. J Ultrasound Med 2003;22:33–38.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7–15.
   PubMed Web of Science ®Google Scholar
• Bottalico JN, Chen X, Tartaglia M, Rosario B, Yarabothu D, Nelson L. Second-trimester genetic sonogram for detection of fetal chromosomal abnormalities in a community-based antenatal testing unit. Ultrasound Obstet Gynecol 2009;33:161–168.
   PubMedGoogle Scholar
• Paladini D, Tartaglione A, Agangi A, Teodoro A, Forleo F, Borghese A, Martinelli P. The association between congenital heart disease and Down syndrome in prenatal life. Ultrasound Obstet Gynecol 2000;15:104–108.
   PubMed Web of Science ®Google Scholar
• Cleves MA, Hobbs CA, Cleves PA, Tilford JM, Bird TM, Robbins JM. Congenital defects among liveborn infants with Down syndrome. Birth Defects Res Part A Clin Mol Teratol 2007;79:657–663.
   PubMed Web of Science ®Google Scholar
• Pont SJ, Robbins JM, Bird TM, Gibson JB, Cleves MA, Tilford JM, Aitken ME. Congenital malformations among liveborn infants with trisomies 18 and 13. Am J Med Genet A 2006;140:1749–1756.
   PubMedGoogle Scholar
• Yagel S. Fetal cardiology. New York: Taylor and Francis group; 2005. pp 80.
   Google Scholar
• Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221–226.
   PubMed Web of Science ®Google Scholar
• Krantz DA, Hallahan TW, Macri VJ, Macri JN. Genetic sonography after first-trimester Down syndrome screening. Ultrasound Obstet Gynecol 2007;29:666–670.
   PubMed Web of Science ®Google Scholar
• Ramos-Corpas DJ, Santiago JC. Combined test + inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down syndrome. Prenat Diagn 2008;28:833–838.
   PubMedGoogle Scholar
• Benn PA, Egan JF. Expected performance of second trimester maternal serum testing followed by a ‘genetic sonogram’ in screening of fetal Down syndrome. Prenat Diagn 2008;28:230–235.
   PubMedGoogle Scholar
• Rozenberg P, Bussières L, Chevret S, Bernard JP, Malagrida L, Cuckle H, Chabry C, et al. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol 2006;195:1379–1387.
   PubMed Web of Science ®Google Scholar
• Benacerraf BR. Ultrasound of fetal syndrome. Philadelphia: Churchill Livingstone; 1998. pp 328.
   Google Scholar
• Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down’s syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998;12:8–14.
   PubMed Web of Science ®Google Scholar
• Benacerraf BR, Frigoletto FD Jr. Soft tissue nuchal fold in the second-trimester fetus: standards for normal measurements compared with those in Down syndrome. Am J Obstet Gynecol 1987;157:1146–1149.
   PubMedGoogle Scholar
• Yagel S, Cohen SM, Achiron R. Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 2001;17:367–369.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Sebire NJ, Snijders R. The 11-14 week scan. London: The Parthenon Publishing Group; 1999.
   Google Scholar
• Cuckle H. Improved parameters for risk estimation in Down’s syndrome screening. Prenat Diagn 1995;15:1057–1065.
   PubMed Web of Science ®Google Scholar
• Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13:231–237.
   PubMed Web of Science ®Google Scholar
• Reynolds TM, Penney MD. The mathematical basis of multivariate risk screening: with special reference to screening for Down’s syndrome associated pregnancy. Ann Clin Biochem 1990;27 (Pt 5):452–458.
   PubMedGoogle Scholar
• Spanish Society of Obstetrics and Gynaecology. http://www.sego.es.
   Google Scholar
• Royal College of Obstetricians and Gynaecologists. http://www.rcog.org.uk.
   Google Scholar
• Aagaard-Tillery KM, Malone FD, Nyberg DA, Porter TF, Cuckle HS, Fuchs K, Sullivan L, et al. Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol 2009;114:1189–1196.
   PubMed Web of Science ®Google Scholar
• Salomon LJ, Chevret S, Bussieres L, Ville Y, Rozenberg P. Down syndrome screening using first-trimester combined tests and contingent use of femur length at routine anomaly scan. Prenat Diagn 2010;30:783–789.
   PubMedGoogle Scholar
• Sainz JA, Serrano R, Turmo E, Almeida C, Caballero V, Garrido R. Contribution of “modified genetic sonography” to the combined test as a screening method for chromosomal abnormalities. J Matern Fetal Neonatal Med 2011, in press.
   PubMedGoogle Scholar
• Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. JAMA 2001;285:1044–1055.
   PubMed Web of Science ®Google Scholar
• Paladini D, Sglavo G, Pastore G, Masucci A, Dármiento MR, Nappi C. Aberrant right subclavian artery (ARSA). Incidence and correlation with other markers of Down syndrome in 2nd trimester fetuses. Ultrasound Obstet Gynecol 2012;39:191–195.
   PubMed Web of Science ®Google Scholar
• Mogra R, Zidere V, Allan LD. Prenatally detectable congenital heart defects in fetuses with Down syndrome. Ultrasound Obstet Gynecol 2011;38:320–324.
   PubMedGoogle Scholar
• Tegnander E, Willians W, Johansen OJ, Blaas HG, Eik-Nes SH. Prenatal detection of heart defects in a non-selected population of 30149 fetuses-detection rates and outcome. Ultrasound Obstet Gynecol 2006;27:252–265.
   PubMed Web of Science ®Google Scholar
• Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002;88:387–391.
   PubMed Web of Science ®Google Scholar
• Achiron R, Glaser J, Gelernter I, Hegesh J, Yagel S. Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. BMJ 1992;304:671–674.
   PubMed Web of Science ®Google Scholar
• Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, Knuppel RA. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 1996;87:948–952.
   PubMed Web of Science ®Google Scholar
• DeVore GR. Trisomy 21: 91% detection rate using second-trimester ultrasound markers. Ultrasound Obstet Gynecol 2000;16:133–141.
   PubMed Web of Science ®Google Scholar
• Clur SA, Oude Rengerink K, Ottenkamp J, Bilardo CM. Cardiac function in trisomy 21 fetuses. Ultrasound Obstet Gynecol 2011;37:163–171.
   PubMed Web of Science ®Google Scholar
• Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 2009;33:18–22.
   PubMed Web of Science ®Google Scholar
• DeVore GR. Genetic sonography: the historical and clinical role of fetal echocardiography. Ultrasound Obstet Gynecol 2010;35:509–521.
   PubMed Web of Science ®Google Scholar
• Clur SAB, Oude Rengerink K, Ottenkamp J, Bilardo CM. Cardiac function in trisomy 21 fetuses. Ultrasound Obstet Gynecol 2011;37:163–171.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217–227.
   Google Scholar
• Muñoz-Cortes M, Arigita M, Falguera G, Seres A, Guix D, Baldrich E, Acera A, et al. Contingent screening for Down syndrome completed in the first trimester: a multicenter study. Ultrasound Obstet Gynecol 2012;39:396–400.
   PubMed Web of Science ®Google Scholar
• Cuckle HS. Growing complexity in the choice of Down’s syndrome screening policy. Ultrasound Obstet Gynecol 2002;19:323–326.
   PubMed Web of Science ®Google Scholar
• Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 2002;100:1168–1176.
   PubMedGoogle Scholar